Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athan Baillet

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
RMD Open|July 18, 2025
When generative artificial intelligence answers to Google Trends about spondyloarthritis: what does a French expert panel think about it?Frank Verhoeven, Olivier Fakih, Corinne Miceli-Richard, et al.
Joint Bone Spine|November 2, 2013
Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for HealthVincent Goëb, Marc Ardizzone, Laurent Arnaud, et al.
Joint Bone Spine|May 20, 2020
Data to be collected for an optimal management of axial spondyloarthritis in daily practice: Proposal from evidence-based and consensual approachesAthan Baillet, Xavier Romand, Arnaud Pflimlin, et al.
Joint Bone Spine|May 25, 2024
Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshopDaniel Wendling, Maxime Breban, Félicie Costantino, et al.
Joint Bone Spine|April 11, 2024
Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiativeAdeline Ruyssen-Witrand, Damien Caillet-Portillo, Aurélie Najm, et al.
Annals of the Rheumatic Diseases|March 18, 2016
Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiativeAthan Baillet, Laure Gossec, Loreto Carmona, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 16, 2021
Mediation of Interleukin-23 and Tumor Necrosis Factor-Driven Reactive Arthritis by Chlamydia-Infected Macrophages in SKG MiceXavier Romand, Xiao Liu, M Arifur Rahman, et al.
Annals of the Rheumatic Diseases|May 7, 2021
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trialAnna Molto, Clementina López-Medina, Filip E Van den Bosch, et al.
Joint Bone Spine|October 10, 2024
2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritisBruno Fautrel, Joanna Kedra, Claire Rempenault, et al.
Annals of the Rheumatic Diseases|August 30, 2025
Effect of intra-articular adipose-derived mesenchymal stromal cell versus placebo injection on pain and function in patients with knee osteoarthritis: the ADIPOA2 phase 2b randomised clinical trialYves-Marie Pers, Hubert Schrezenmeier, Sandrine Fleury-Cappellesso, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
RMD Open|July 18, 2025
When generative artificial intelligence answers to Google Trends about spondyloarthritis: what does a French expert panel think about it?Frank Verhoeven, Olivier Fakih, Corinne Miceli-Richard, et al.
Joint Bone Spine|November 2, 2013
Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for HealthVincent Goëb, Marc Ardizzone, Laurent Arnaud, et al.
Joint Bone Spine|May 20, 2020
Data to be collected for an optimal management of axial spondyloarthritis in daily practice: Proposal from evidence-based and consensual approachesAthan Baillet, Xavier Romand, Arnaud Pflimlin, et al.
Joint Bone Spine|May 25, 2024
Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshopDaniel Wendling, Maxime Breban, Félicie Costantino, et al.
Joint Bone Spine|April 11, 2024
Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiativeAdeline Ruyssen-Witrand, Damien Caillet-Portillo, Aurélie Najm, et al.
Annals of the Rheumatic Diseases|March 18, 2016
Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiativeAthan Baillet, Laure Gossec, Loreto Carmona, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 16, 2021
Mediation of Interleukin-23 and Tumor Necrosis Factor-Driven Reactive Arthritis by Chlamydia-Infected Macrophages in SKG MiceXavier Romand, Xiao Liu, M Arifur Rahman, et al.
Annals of the Rheumatic Diseases|May 7, 2021
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trialAnna Molto, Clementina López-Medina, Filip E Van den Bosch, et al.
Joint Bone Spine|October 10, 2024
2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritisBruno Fautrel, Joanna Kedra, Claire Rempenault, et al.
Annals of the Rheumatic Diseases|August 30, 2025
Effect of intra-articular adipose-derived mesenchymal stromal cell versus placebo injection on pain and function in patients with knee osteoarthritis: the ADIPOA2 phase 2b randomised clinical trialYves-Marie Pers, Hubert Schrezenmeier, Sandrine Fleury-Cappellesso, et al.
Pageof 9